Long-term drug survival and causes of discontinuation of subcutaneous abatacept in rheumatoid arthritis: 32-month results from a prospective cohort study

Background Survival time or time to discontinuation of medication is a surrogate of the long-term impact on the course of disease in real life. It reflects clinical effectiveness in the absence of significant adverse events [1]. Treatment discontinuation can result from loss of efficacy or safety co...

Descripción completa

Detalles Bibliográficos
Autores Principales: Sarmiento-Monroy, JC, Molano-González, Nicolas, Rodríguez-Jímenez, Mónica, Mantilla, RD
Formato: Artículo (Article)
Lenguaje:Inglés (English)
Publicado: European League Against Rheumatism 2017
Acceso en línea:https://repository.urosario.edu.co/handle/10336/28079